Literature DB >> 18706274

Melanoma and the tumor microenvironment.

Jessie Villanueva1, Meenhard Herlyn.   

Abstract

Melanoma arises through the accrual of mutations in genes critical for proliferation and survival. Although melanoma had been traditionally conceptualized as a cell-autonomous event, increasing evidence supports the notion that these tumors are not isolated entities but rather depend, interact with, and react to the adjacent microenvironment. Melanoma is composed of not only the malignant cells but also the supporting stroma, which includes fibroblasts, endothelial cells, immune cells, soluble molecules, and the extracellular matrix (ECM). Tumor cells actively interact with the microenvironment in a bidirectional manner through molecular signals that modulate the malignant phenotype. This article briefly reviews the molecular basis of melanomagenesis as well as the interplay of melanoma with other cells of the tumor microenvironment and components of the ECM. It also discusses the influence of the microenvironment on therapeutic targeting of melanoma, highlighting recent studies that propose novel strategies to target tumor-microenvironment interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706274      PMCID: PMC5662003          DOI: 10.1007/s11912-008-0067-y

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  50 in total

1.  Shear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin alphavbeta3.

Authors:  Karen Lawler; Gerardene Meade; Gerald O'Sullivan; Dermot Kenny
Journal:  Am J Physiol Cell Physiol       Date:  2004-07-07       Impact factor: 4.249

Review 2.  Selective evolutionary pressure from the tissue microenvironment drives tumor progression.

Authors:  Keiran S M Smalley; Patricia A Brafford; Meenhard Herlyn
Journal:  Semin Cancer Biol       Date:  2005-12       Impact factor: 15.707

3.  Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail.

Authors:  I Poser; D Domínguez; A G de Herreros; A Varnai; R Buettner; A K Bosserhoff
Journal:  J Biol Chem       Date:  2001-04-25       Impact factor: 5.157

4.  Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.

Authors:  S Ugurel; G Rappl; W Tilgen; U Reinhold
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

5.  Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.

Authors:  E Petitclerc; S Strömblad; T L von Schalscha; F Mitjans; J Piulats; A M Montgomery; D A Cheresh; P C Brooks
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

Review 6.  Matrix metalloproteinases in human melanoma.

Authors:  U B Hofmann; J R Westphal; G N Van Muijen; D J Ruiter
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

Review 7.  The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma.

Authors:  Friedegund Meier; Birgit Schittek; Silke Busch; Claus Garbe; Keiran Smalley; Kapaettu Satyamoorthy; Gang Li; Meenhard Herlyn
Journal:  Front Biosci       Date:  2005-09-01

8.  Focal adhesion kinase promotes the aggressive melanoma phenotype.

Authors:  Angela R Hess; Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Galen B Schneider; Richard E B Seftor; Brian J Nickoloff; Mary J C Hendrix
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

9.  Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.

Authors:  Christian Fischer; Bart Jonckx; Massimiliano Mazzone; Serena Zacchigna; Sonja Loges; Lucia Pattarini; Emmanuel Chorianopoulos; Laurens Liesenborghs; Marta Koch; Maria De Mol; Monica Autiero; Sabine Wyns; Stephane Plaisance; Lieve Moons; Nico van Rooijen; Mauro Giacca; Jean-Marie Stassen; Mieke Dewerchin; Desire Collen; Peter Carmeliet
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

Review 10.  Angiogenesis in melanoma.

Authors:  Ganapati H Mahabeleshwar; Tatiana V Byzova
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

View more
  76 in total

Review 1.  The role of Orai-STIM calcium channels in melanocytes and melanoma.

Authors:  Hedwig Stanisz; Adina Vultur; Meenhard Herlyn; Alexander Roesch; Ivan Bogeski
Journal:  J Physiol       Date:  2016-04-06       Impact factor: 5.182

Review 2.  Beyond 3D culture models of cancer.

Authors:  Kandice Tanner; Michael M Gottesman
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

Review 3.  PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.

Authors:  Maya Zigler; Takafumi Kamiya; Emily C Brantley; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

4.  Comparative protein profiling of B16 mouse melanoma cells susceptible and non-susceptible to alphavirus infection: Effect of the tumor microenvironment.

Authors:  Jelena Vasilevska; Gustavo Antonio De Souza; Maria Stensland; Dace Skrastina; Dmitry Zhulenvovs; Raimonds Paplausks; Baiba Kurena; Tatjana Kozlovska; Anna Zajakina
Journal:  Cancer Biol Ther       Date:  2016-09-16       Impact factor: 4.742

5.  Deconstructing the role of the ECM microenvironment on drug efficacy targeting MAPK signaling in a pre-clinical platform for cutaneous melanoma.

Authors:  Benjamin H Blehm; Nancy Jiang; Yorihisa Kotobuki; Kandice Tanner
Journal:  Biomaterials       Date:  2015-04-17       Impact factor: 12.479

6.  RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues.

Authors:  Keren Yizhak; François Aguet; Jaegil Kim; Julian M Hess; Kirsten Kübler; Jonna Grimsby; Ruslana Frazer; Hailei Zhang; Nicholas J Haradhvala; Daniel Rosebrock; Dimitri Livitz; Xiao Li; Eila Arich-Landkof; Noam Shoresh; Chip Stewart; Ayellet V Segrè; Philip A Branton; Paz Polak; Kristin G Ardlie; Gad Getz
Journal:  Science       Date:  2019-06-07       Impact factor: 47.728

Review 7.  Biomimetic human lung-on-a-chip for modeling disease investigation.

Authors:  Kaiyan Li; Xingyuan Yang; Chang Xue; Lijuan Zhao; Yuan Zhang; Xinghua Gao
Journal:  Biomicrofluidics       Date:  2019-06-27       Impact factor: 2.800

8.  The β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts.

Authors:  Tianyi Liu; Linli Zhou; Kun Yang; Kentaro Iwasawa; Ana Luisa Kadekaro; Takanori Takebe; Thomas Andl; Yuhang Zhang
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

9.  Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?

Authors:  Nikolas K Haass
Journal:  Melanoma Manag       Date:  2015-05-18

10.  The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis.

Authors:  Xu Zhang; Zunnan Huang; Yeye Guo; Ta Xiao; Ling Tang; Shuang Zhao; Lisha Wu; Juan Su; Weiqi Zeng; Hongbin Huang; Zheng Li; Juan Tao; Jianda Zhou; Xiang Chen; Cong Peng
Journal:  Oncogene       Date:  2020-04-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.